SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-09-009950
Filing Date
2009-06-19
Accepted
2009-06-19 17:51:36
Documents
2
Period of Report
2009-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3843
2 ex24hurwitz.txt EX-24 3153
  Complete submission text file 0001179110-09-009950.txt   8790
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
HURWITZ EDWARD (Reporting) CIK: 0001211840 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 09902156